Financials

Company Profile

EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.

Employees

Sector

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

09/10/18	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
31/01/18	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI

09/10/18	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
31/01/18	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI
19/01/18	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
18/01/18	Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	CI
11/12/17	Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	CI
19/09/16	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
05/08/16	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from S&P TMI Index	CI
03/08/16	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from NASDAQ Composite Index	CI
25/07/16	EPIRUS Biopharmaceuticals, Inc. Announces Management Resignations	CI
25/07/16	EPIRUS Biopharmaceuticals, Inc. Filed for Bankruptcy	CI
02/07/16	EPIRUS Biopharmaceuticals, Inc. Announces Executive Termination	CI
30/06/16	Polpharma S.A. completed the acquisition of EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc..	CI
14/06/16	Polpharma S.A. entered into a binding term sheet to acquire EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc. for $3.5 million.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EPIRUS BIOPHARMACEUTICALS, INC.	-.--%	-.--%	-	-	26
LONZA GROUP AG	+0.99%	+1.78%	+5.07%	+16.49%	49.47B
REVOLUTION MEDICINES, INC.	+3.71%	+9.40%	+486.14%	+579.98%	43.97B
BEONE MEDICINES AG	+5.60%	+10.21%	+20.85%	+81.78%	39.6B
IQVIA HOLDINGS INC.	+2.70%	+1.57%	+32.71%	+9.07%	39.29B
CELLTRION, INC.	+2.21%	+6.75%	+20.20%	+54.40%	32.43B
ASCENDIS PHARMA A/S	+2.23%	+4.71%	-	-	16.84B
MEDPACE HOLDINGS, INC.	+0.97%	+2.35%	+35.99%	+124.45%	16.49B
EUROFINS SCIENTIFIC SE	-0.11%	+2.41%	+5.03%	+20.47%	14.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.75%	+15.04%	+79.84%	+29.70%	12.77B
Average	+1.90%	+5.69%	+85.73%	+114.54%	26.49B
Weighted average by Cap.	+2.54%	+6.10%	+105.13%	+138.67%